ArticleCureus2026
Feasibility of Neuromuscular Electrical Stimulation in a Young Patient With Hematological Malignancy Unable to Perform Active Exercise: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with hematological malignancies often have difficulty performing aerobic and resistance exercises because of the disease and the adverse effects from chemotherapy. Neuromuscular electrical stimulation (NMES) may provide an alternative rehabilitation option for patients with cancer who cannot perform conventional exercise therapy. However, the safety and feasibility of NMES in patients with severe thrombocytopenia remain unclear. This case report describes the feasibility of NMES during chemotherapy in a young patient with B-cell acute lymphoblastic leukemia (B-cell ALL), severe thrombocytopenia, and cachexia. The patient was a woman in her 20s with B-cell ALL and cachexia. Severe fatigue and thrombocytopenia prevented her from performing aerobic or resistance exercises. After consultation with a physiatrist and hematologist, belt-electrode NMES was introduced to maintain and improve muscle strength. The hematologist approved NMES use regardless of platelet (Plt) count, provided the purpose was to induce muscle contraction. Belt electrodes were applied to the trunk, thighs, and lower legs. NMES was administered at 20 Hz for 20 minutes with a duty cycle of 5 seconds of stimulation followed by 2 seconds of rest. The stimulation intensity was set at the maximum tolerable level that produced visible muscle contractions. Pain, discomfort, and petechial bleeding were monitored during and after NMES. No adverse events, such as bleeding or skin reactions, were observed, even when the Plt count dropped to 19,000/μL. In this case, NMES was feasible and was performed safely in a patient with B-cell ALL who was unable to perform conventional exercise therapy during chemotherapy. This case demonstrates that NMES was feasible and well tolerated under the reported stimulation parameters in one patient with B-cell ALL; confirmation through prospective studies with larger samples is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.